Connect with us

Health

Global Health Inequities Persist as Progress on Life Expectancy and Mortality Slows, Says WHO

Published

on

While the world has made significant strides in narrowing health disparities between rich and poor nations over the past two decades, progress is now faltering — and in some cases reversing — according to a new report by the World Health Organization (WHO).

The report, the WHO’s first comprehensive analysis on health equity since 2008, finds that although gaps in life expectancy, child mortality, and maternal health have narrowed globally, none of the agency’s long-term health targets for 2040 are currently on track to be met.

There has been some progress narrowing health gaps between countries, but it is stalling,” said Dr. Sudhvir Singh, who leads the WHO’s equity and health unit, during a press briefing. He called for urgent action to address the underlying social, political, and economic factors driving health inequalities.

The WHO’s 2040 targets include halving the gap in life expectancy between countries, reducing adult mortality by half, slashing child deaths under age five by 90 percent, and cutting maternal mortality by 95 percent. Yet, the latest figures reveal that progress toward these goals has slowed dramatically.

A stark example is life expectancy. While people in high-income countries such as Japan enjoy an average lifespan of 84.5 years, those in countries like Lesotho live on average only 51.5 years — a gap of 33 years. The global average gap still stands at 12.5 years, well short of the WHO’s goal to reduce it to 8.2 years by 2040.

Child mortality has improved significantly, with global rates dropping from 77 deaths per 1,000 live births in 2000 to 37 in 2023. But children in low-income nations remain 13 times more likely to die before age five compared to those in wealthier countries. The WHO’s target of eight deaths per 1,000 by 2040 appears increasingly out of reach.

See also  EU Households Shoulder 15% of Health Costs, But Burden Varies Sharply Across Europe

Maternal mortality has declined by 40 percent since 2000, yet the current global rate remains at 197 deaths per 100,000 live births — more than twelve times higher than the 2040 goal of just 16.

The report also highlights major disparities within countries. Poorer communities, women, ethnic minorities, and other marginalized groups continue to face worse health outcomes due to factors such as income inequality, poor access to public services, systemic discrimination, and environmental threats like climate change.

WHO officials warned that climate change alone could push up to 135 million people into extreme poverty in the next five years — further widening health gaps unless governments act decisively.

There’s a very positive return on investment from addressing these social determinants of health,” said Singh. “And there’s a huge cost of inaction.”

Health

Sperm Donor with Cancer-Causing Mutation Fathers Nearly 200 Children Across Europe

Published

on

A sperm donor carrying a rare cancer-causing genetic mutation has fathered nearly 200 children across Europe, according to an investigation led by the European Broadcasting Union, involving 14 public service broadcasters. The man, who appeared healthy and passed standard screening, donated sperm for approximately 17 years while he was a student.

The mutation, found in the TP53 gene, increases the risk of cells becoming cancerous. Children who inherit the mutation develop Li Fraumeni syndrome, a disorder associated with up to a 90 percent lifetime risk of cancer. Some donor-conceived children have already died, and many more are expected to develop cancer in the future.

Doctors first identified the risk this year after discovering 23 children carrying the mutation among 67 known cases, 10 of whom had already been diagnosed with cancer. Investigators reported that the donor’s sperm was used to conceive at least 197 children in 14 countries, though the actual number may be higher. Children have been born in Denmark, Belgium, Spain, Greece, and Germany, with additional recipients in Ireland, Poland, Albania, Kosovo, and Sweden. A small number of women from the United Kingdom were also treated at clinics in Denmark, according to Peter Thompson, chief executive of the UK’s Human Fertilisation and Embryology Authority.

Denmark’s European Sperm Bank, which supplied the samples, admitted the sperm was overused and expressed “deepest sympathy” to affected families. The bank said the mutation could not have been detected through routine screening and immediately blocked the donor once the problem was discovered.

Experts have described the case as both a regulatory failure and an extraordinary coincidence. Jackson Kirkman-Brown, a professor at the University of Birmingham, noted that detecting new mutations in sperm is difficult and that the core issue lies in insufficient monitoring of how often a single donor’s sperm is used. Clare Turnbull from the UK Institute of Cancer Research said the situation reflects a highly unusual combination: a donor carrying a rare mutation and that same sperm being used to create a large number of children. She added that the mutation likely arose in the donor’s testes and spread among sperm cells, a phenomenon known as selfish spermatogonial selection.

See also  New Research Suggests Daily Orange Juice Consumption May Influence Thousands of Genes Linked to Heart Health

The investigation has also highlighted differences in European regulations on sperm donation. Family and child limits vary widely: in Cyprus, a donor may contribute to only one child, while France, Greece, Italy, and Poland allow up to 10. Denmark limits donations to 12 families, and Sweden and Norway to six families. Some countries maintain anonymous donations, though disclosure may occur in cases of severe health conditions.

Euronews Health has contacted the European Sperm Bank for comment but has not yet received a response. The case has renewed calls from experts for tighter international oversight of sperm donation to prevent similar incidents in the future.

Continue Reading

Health

AI Note-Taking Tool Gives European Clinicians More Time With Patients, Study Finds

Published

on

A new analysis from Swedish firm Tandem Health suggests that automated note-taking technology is reducing paperwork for clinicians across Europe and allowing them to spend more meaningful time with patients.

The company reviewed more than 375,000 medical notes produced with its AI scribe, a tool now used by nearly 1,300 clinicians in 11 European countries, including the UK, France and Spain. The findings indicate that the technology shortened the average time spent writing notes from 6.69 minutes to 4.71 minutes — a 29% drop.

Tandem Health also surveyed 177 clinicians, ranging from GPs and surgeons to psychologists and nurses. Many said the reduction in administrative work allowed them to feel more attentive during consultations, while some reported a noticeable decrease in stress linked to routine documentation.

Health workforce fatigue remains a growing concern in Europe. An international survey published earlier this year found that administrative overload is a major factor behind burnout among primary care doctors. In the UK, 28% of GPs who reported burnout said excessive paperwork was the main cause. In Switzerland, the proportion rose to 65%.

Tandem Health CEO Lukas Saari said the results highlight how digital tools could support overstretched services. “For European healthcare systems facing acute workforce shortages and rising costs, that capacity gain could make a real difference at scale, addressing wait times, clinician burnout and care access,” he said.

The company stressed that much of the existing research on AI scribes comes from the United States, where healthcare structures differ significantly from those in Europe. Tandem Health’s scribe is classified as a medical device under EU rules, and the firm says more regional evidence is necessary as adoption grows.

See also  Novartis’ New Drug Shows Strong Results Against Malaria, Offering Hope Amid Rising Resistance

Dr Artin Entezarjou, head of medical operations at Tandem Health, said the data offers insight for policymakers and health leaders examining new ways to address persistent staffing pressures. He noted that European systems must understand how such tools function in their own clinical environments to shape appropriate guidance and investment decisions.

Supporters of the technology argue that even modest efficiency gains could help reduce appointment backlogs and ease strain on health workers. Many clinicians in the survey said the extra time and reduced cognitive load improved the quality of their patient interactions, which they viewed as a central benefit of the scribe.

The findings arrive as hospitals and primary care networks across Europe continue to test digital tools that could take on repetitive administrative duties. Tandem Health says demand for its scribe has risen sharply over the past year as more clinicians explore ways to streamline paperwork without compromising record accuracy.

The company plans to expand data collection to assess long-term effects on patient flow, clinical workload and staff retention.

Continue Reading

Health

Global Study Finds Sleep May Play Greater Role Than Exercise in Overall Health

Published

on

A major international study has found that only a small share of people manage to meet recommended levels of both sleep and daily physical activity, raising new questions about long-standing health guidelines and how people can realistically follow them.

The research, published in the journal Communications Medicine, analysed data from wearable sleep and activity trackers from more than 70,000 people across multiple regions over a period of three and a half years. The findings show that only about 13 per cent consistently achieved the commonly promoted targets of seven to nine hours of sleep each night and at least 8,000 steps per day.

Lead author Josh Fitton, a sleep researcher at Flinders University in Australia, said the results highlight the gap between public health recommendations and everyday routines. “Only a tiny fraction of people can achieve both recommended sleep and activity levels every day, so we really need to think about how these guidelines work together and what we can do to support people to meet them in ways that fit real life,” he said.

The study revealed that people often manage to either get sufficient rest or maintain an active routine, but struggle to sustain both. Nearly 17 per cent of participants averaged fewer than seven hours of sleep and fewer than 5,000 steps daily, placing them in what researchers described as a “sedentary” group. This combination has been linked in past studies to a higher likelihood of chronic illness, weight gain and mental health issues.

Researchers noted that the data has limitations, as tracking devices tend to be more commonly used in higher-income countries, potentially skewing the global representation. Even so, the analysis uncovered a consistent pattern across participants: those who slept between six and seven hours a night recorded the highest number of steps the next day.

See also  UK Scientists Develop Urine Test for Early Lung Cancer Detection

Senior author Danny Eckert, also from Flinders University, said the findings suggest that sleep may play a stronger role than many realise in shaping daily energy and activity levels. “Prioritising sleep could be the most effective way to boost your energy, motivation, and capacity for movement,” he said.

He added that small adjustments can help people build healthier routines. This includes reducing screen exposure before bed, maintaining regular sleep schedules and creating calming nighttime environments to support better rest.

The study’s authors say the results point to a need for clearer and more practical guidance, especially for people who struggle to balance work, family responsibilities and personal health goals. They say that for many, improving sleep habits may be the most realistic first step toward leading more active and healthier lives.

Continue Reading

Trending